Innovation Pharmaceuticals Inc (IPIX)

[iclight]

"I also find the spleen lesion disappeared in one ovarian patient at medium dosage hard to believe. But it actually happened. "

That's great but not really what I'm discussing.

The 750 cohort is done. It was started prior to the ASCO abstract which was submitted in Feb of this year. 6 months ago. If there was even a partial response (your tumor shrinkage) that would have been PRed instead of the SD ovarian patients.